Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-10,686
Closed -$144K 657
2026
Q1
$144K Sell
10,686
-56
-0.5% -$784 ﹤0.01% 687
2025
Q4
$134K Buy
+10,742
New +$116K ﹤0.01% 653
2022
Q4
Sell
-1,165
Closed -$10K 1128
2022
Q3
$10K Sell
1,165
-434
-27% -$4.27K ﹤0.01% 759
2022
Q2
$17K Buy
1,599
+334
+26% +$3.66K ﹤0.01% 688
2022
Q1
$14K Sell
1,265
-17
-1% -$224 ﹤0.01% 720
2021
Q4
$17K Buy
1,282
+1
+0.1% +$13 ﹤0.01% 709
2021
Q3
$17K Sell
1,281
-370
-22% -$5.25K ﹤0.01% 665
2021
Q2
$24K Sell
1,651
-501
-23% -$7.25K ﹤0.01% 628
2021
Q1
$30K Buy
2,152
+258
+14% +$4.21K ﹤0.01% 521
2020
Q4
$35K Buy
+1,894
New +$30.9K ﹤0.01% 415
2020
Q2
Sell
-16
Closed -$239 1199
2020
Q1
$239 Sell
16
-28
-64% -$536 ﹤0.01% 1079
2019
Q4
$884 Sell
44
-154
-78% -$2.87K ﹤0.01% 1155
2019
Q3
$3.92K Buy
+198
New +$3.88K ﹤0.01% 1062

Other funds holding VTRS

Evoke Wealth's VTRS Position: Q2 2026 in Review

Evoke Wealth sold out of Viatris (VTRS) in Q2 2026, closing a stake of 10,686 shares — an estimated $144K sold.

Evoke Wealth first reported a position in VTRS in Q3 2019 and held it in 13 quarters. The position peaked at $144K in Q1 2026. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Evoke Wealth reported no remaining Viatris position as of Q2 2026 after selling out during the quarter.
  • Evoke Wealth sold 10,686 Viatris shares in Q2 2026, an estimated $144K.
  • Evoke Wealth first reported a position in Viatris in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Viatris position peaked at $144K in Q1 2026.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Evoke Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.